**17. Rehabilitation**

Quality of life and psychosocial outcomes following treatment of medulloblastoma are progressively recognized as crucial issues in decision-making regarding therapy. Long-term outcome was less emphasized than survival previously as survival was nominal in the earlier period of history of medulloblastoma, though the thought of prolongation of life and making it worth living was always there with the encouragement to persist in efforts [2]. Over the past decades, survival has improved significantly, and expectantly will continue to improve with the development of molecularly targeted agents and other modalities of treatment. With time, thoughts regarding quality of life is becoming increasingly vital both in decisionmaking concerning therapy and in the design of future treatment protocols where quality of life is the prime target next to survival [6]. Treatment-related endocrinologic, cognitive, and psychological sequelae, especially in Infants and very young children with medulloblastoma remain a difficult therapeutic challenge which can be tackled prudently with rehabilitation programs. For that it is an obvious need to develop active rehabilitative programs and special educational assistance for the children who survive the multi-modality therapy [71]. Optimum therapy has led to long-term survival in patients of medulloblastoma and it is expected to be increased with time with the anticipated need of more intense and dedicated rehabilitation regime for this group of patients. Thus the long-term survivors of medulloblastoma badly require multifaceted medical rehabilitation care involving team of subspecialists including oncologist, neurologist, endocrinologist, psychologist, psychiatrist and physiotherapist to overcome the challenges that they have to face in the longer run [8, 64].
